Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

The ability of natural flavonoids to inhibit SARS-CoV-2

A recent systematic review discusses naturally occurring flavonoids as a promising antiviral alternative against SARS-CoV-2.

31 Oct 2021

Environmental and social factors associated with higher rates of pediatric pneumonia

A new study led by researchers in the Louisiana State University Superfund Research Program demonstrates that children who are exposed to a certain type of environmental air pollution are more likely to contract community acquired pneumonia, or CAP, and to be hospitalized for longer periods of time.

29 Oct 2021

Study finds immunity against SARS-CoV-2 delta variant waned after BNT162b2 vaccine second dose

Researchers from Israel have investigated the possibility that vaccine-induced immunity reduces over time and potential causes and risk factors.

29 Oct 2021

SARS-CoV-2 incidence and mortality in US school opening model

Researchers reported regional variations on the impact of school reopening policy on the community rate of SARS-CoV-2 infection.

29 Oct 2021

Causal effect of school closures on reducing COVID-19 spread in Japan

A new study estimated the causal effect of school closures on reducing the spread of COVID-19.

29 Oct 2021

Study finds early fluvoxamine treatment among COVID-19 patients reduces hospitalization

A team of researchers conducted a randomized, placebo-controlled, adaptive platform trial to evaluate the efficacy of fluvoxamine to prevent COVID-19 progression and hospitalization.

29 Oct 2021

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Researchers analyze an outbreak of breakthrough infections in a small nursing home in Northerneastern Italy.

28 Oct 2021

How long does natural or vaccine-induced immunity to COVID last?

Researchers present a comprehensive assessment on SARS-CoV-2 induced immunity.

28 Oct 2021

Importance of boosters after priming with J&J Ad26.COV2.S COVID-19 vaccine

A new study compares healthcare workers who underwent homologous Ad26.COV2.S booster vaccination to those who underwent heterologous boosting.

28 Oct 2021

A novel approach to improve the stability of Remdesivir

A recent study discusses a novel method to enhance the stability of Remdesivir.

28 Oct 2021

Study suggests third dose of the Pfizer vaccine could reduce SARS-CoV-2 transmission

A new study examined protection against symptomatic coronavirus disease 2019 (COVID-19) from non-Delta variants using data from randomized control trials.

28 Oct 2021

Structure of human-infecting canine coronavirus HuPn-2018 spike glycoprotein

As CCoV-HuPn-2018 has been recently isolated in a child's respiratory swab, researchers from the University Of Washington have been examining the structure of the virus.

28 Oct 2021

Study finds one mRNA vaccine dose after SARS-CoV-2 infection produces highest neutralizing antibody titers

Researchers investigated the neutralizing antibody response that different mRNA vaccines induce in both previously convalescent and SARS-CoV-2 naïve individuals.

28 Oct 2021

Panel of broadly neutralizing SARS-CoV-2 nanobodies for immune assay application

In this study, a team of researchers from Japanese institutions provide a panel of broadly neutralizing nanobodies that detect four VOCs.

28 Oct 2021

Two-dose SARS-CoV-2 vaccine effectiveness against infection and hospitalization in Canada

Authors from varying Canadian institutes report on two-dose vaccine effectiveness against infection and hospitalization.

28 Oct 2021

Japanese study on SARS-CoV-2 breakthrough infections

Researchers evaluated SARS-CoV-2 incidence in Japan regarding the timing of the vaccination program and surge in COVID-19 cases among the staff of a large referral hospital in Tokyo. This study is posted to the medRxiv* preprint server.

28 Oct 2021

N antibodies following SARS-CoV-2 Alpha and Delta infections by vaccination status

A new study, published on the medRxiv* preprint server, has focused on the use of anti-nucleocapsid (N) antibody positivity as a marker of SARS-CoV-2 infection. In the present study, these antibody markers were evaluated using serological surveillance studies post-vaccination amidst circulation of variants of concern.

28 Oct 2021

Routine surveillance helps detect asymptomatic SARS-CoV-2 vaccine breakthrough infections

In a study published in Annals of Internal Medicine, researchers from Italy systematically monitored 2,397 HCWs who were fully vaccinated with BNT162 at the ASST Settelaghi hospitals in Lombardy, Italy during February 2021. HCWs who worked in 8 wards deemed at “high risk” for infection from attending patients had to undergo mandatory nasopharyngeal swab testing with SARS-CoV-2 polymerase chain reaction every two weeks. HCWs working in 8 “moderate-risk” wards were tested every four weeks.

28 Oct 2021

COVID vaccines deployed in US highly effective at reducing hospitalizations and deaths

Researchers in the United States have conducted a large-scale study showing that the two-dose regimen vaccines developed by Pfizer-BioNTech and Moderna to protect against coronavirus disease 2019 (COVID-19) appear to be highly effective and durable in reducing the risk of hospitalizations and deaths following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Oct 2021

SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection

Researchers at the University of Oxford have conducted a study showing that vaccination against coronavirus disease 2019 (COVID-19) is associated with a lower risk of several sequelae among those who experience breakthrough infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Oct 2021

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

The ability of natural flavonoids to inhibit SARS-CoV-2

Environmental and social factors associated with higher rates of pediatric pneumonia

Study finds immunity against SARS-CoV-2 delta variant waned after BNT162b2 vaccine second dose

SARS-CoV-2 incidence and mortality in US school opening model

Causal effect of school closures on reducing COVID-19 spread in Japan

Study finds early fluvoxamine treatment among COVID-19 patients reduces hospitalization

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

How long does natural or vaccine-induced immunity to COVID last?

Importance of boosters after priming with J&J Ad26.COV2.S COVID-19 vaccine

A novel approach to improve the stability of Remdesivir

Study suggests third dose of the Pfizer vaccine could reduce SARS-CoV-2 transmission

Structure of human-infecting canine coronavirus HuPn-2018 spike glycoprotein

Study finds one mRNA vaccine dose after SARS-CoV-2 infection produces highest neutralizing antibody titers

Panel of broadly neutralizing SARS-CoV-2 nanobodies for immune assay application

Two-dose SARS-CoV-2 vaccine effectiveness against infection and hospitalization in Canada

Japanese study on SARS-CoV-2 breakthrough infections

N antibodies following SARS-CoV-2 Alpha and Delta infections by vaccination status

Routine surveillance helps detect asymptomatic SARS-CoV-2 vaccine breakthrough infections

COVID vaccines deployed in US highly effective at reducing hospitalizations and deaths

SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in